DE20004692U1
(de)
|
2000-03-14 |
2001-07-26 |
Sofamor Danek Gmbh |
Wirbelimplantat zum Einschrauben in einen Wirbelzwischenraum
|
WO1994026892A1
(fr)
*
|
1993-05-12 |
1994-11-24 |
Genetics Institute, Inc. |
Compositions de bmp-11
|
US5906827A
(en)
*
|
1994-06-03 |
1999-05-25 |
Creative Biomolecules, Inc. |
Matrix for the manufacture of autogenous replacement body parts
|
US5846770A
(en)
*
|
1994-11-22 |
1998-12-08 |
Genetics Institute, Inc. |
DNA molecules encoding human chordin
|
US5645084A
(en)
*
|
1995-06-07 |
1997-07-08 |
Danek Medical, Inc. |
Method for spinal fusion without decortication
|
US5635372A
(en)
*
|
1995-05-18 |
1997-06-03 |
Genetics Institute, Inc. |
BMP-15 compositions
|
CN1133462C
(zh)
|
1995-06-05 |
2004-01-07 |
遗传学研究所有限责任公司 |
用于修复和愈合连接组织附着的方法和组合物
|
US5902785A
(en)
*
|
1995-06-06 |
1999-05-11 |
Genetics Institute, Inc. |
Cartilage induction by bone morphogenetic proteins
|
US5989289A
(en)
|
1995-10-16 |
1999-11-23 |
Sdgi Holdings, Inc. |
Bone grafts
|
US6423095B1
(en)
|
1995-10-16 |
2002-07-23 |
Sdgi Holdings, Inc. |
Intervertebral spacers
|
US5700774A
(en)
*
|
1996-03-26 |
1997-12-23 |
Genetics Institute, Inc. |
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
|
US5965403A
(en)
|
1996-09-18 |
1999-10-12 |
Genetics Institute, Inc. |
Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
|
AU732421B2
(en)
|
1996-10-23 |
2001-04-26 |
Warsaw Orthopedic, Inc. |
Spinal spacer
|
US6037519A
(en)
|
1997-10-20 |
2000-03-14 |
Sdgi Holdings, Inc. |
Ceramic fusion implants and compositions
|
EP2332564A1
(fr)
|
1997-02-07 |
2011-06-15 |
Stryker Corporation |
Dispositif ostéogenique sans matrice, implants et méthodes d'utilisation associées
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
TW562807B
(en)
*
|
1997-04-01 |
2003-11-21 |
Chugai Pharmaceutical Co Ltd |
Novel secretory membrane protein
|
EP2309261A1
(fr)
|
1997-05-30 |
2011-04-13 |
Stryker Corporation |
Procédés d'évaluation de la morphogénèse de tissus et activité
|
US5972368A
(en)
*
|
1997-06-11 |
1999-10-26 |
Sdgi Holdings, Inc. |
Bone graft composites and spacers
|
US20020052026A1
(en)
|
1997-10-08 |
2002-05-02 |
Steven M. Vicik |
Methods of refolding proteins
|
US6511509B1
(en)
|
1997-10-20 |
2003-01-28 |
Lifenet |
Textured bone allograft, method of making and using same
|
WO1999029719A2
(fr)
*
|
1997-12-09 |
1999-06-17 |
Ontogeny, Inc. |
Facteurs pancreatiques derives, et utilisations s'y rapportant
|
US6027917A
(en)
*
|
1997-12-10 |
2000-02-22 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
|
US7147839B2
(en)
|
1998-05-29 |
2006-12-12 |
Curis, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
WO2000007528A1
(fr)
|
1998-08-06 |
2000-02-17 |
Sdgi Holdings, Inc. |
Separateurs osseux intervertebraux composites
|
WO2002056800A2
(fr)
|
2000-12-08 |
2002-07-25 |
Osteotech, Inc. |
Implant pour applications orthopediques
|
US6752831B2
(en)
|
2000-12-08 |
2004-06-22 |
Osteotech, Inc. |
Biocompatible osteogenic band for repair of spinal disorders
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
WO2003046188A1
(fr)
*
|
2001-11-27 |
2003-06-05 |
Nexyte Ab |
Production de molecules de proteines et d'acides nucleiques eucaryotes dans c. elegans
|
CH695985A5
(de)
|
2002-01-21 |
2006-11-15 |
Straumann Holding Ag |
Oberflächenmodifizierte Implantate.
|
EP1504033A2
(fr)
|
2002-05-03 |
2005-02-09 |
Millenium Biologix Inc. |
Peptides stimulant un tissu conjonctif
|
DE602004005477T2
(de)
|
2003-09-12 |
2007-12-13 |
Wyeth |
Injizierbare feste Calciumphosphat-Stäbe zur Abgabe von osteogenen Proteinen
|
PL1737734T3
(pl)
|
2004-03-10 |
2011-02-28 |
Scil Tech Gmbh |
Powlekane implanty, ich wytwarzanie i zastosowanie
|
AU2005229072A1
(en)
|
2004-03-26 |
2005-10-13 |
Acceleron Pharma Inc. |
BMP-3 propeptides and related methods
|
US7575751B2
(en)
|
2004-04-27 |
2009-08-18 |
Research Development Foundation |
Activin-A mutants
|
WO2005113590A2
(fr)
*
|
2004-05-12 |
2005-12-01 |
Acceleron Pharma Inc. |
Propeptides de bmp10 et procédés correspondants
|
ATE515268T1
(de)
|
2004-05-25 |
2011-07-15 |
Stryker Corp |
Verwendung von op-1 zur behandlung von knorpeldefekten
|
US7749268B2
(en)
|
2004-05-26 |
2010-07-06 |
Warsaw Orthopedic, Inc. |
Methods for treating the spine
|
EP1771557B1
(fr)
|
2004-06-24 |
2014-12-31 |
Acceleron Pharma Inc. |
Propeptides GDF3 et méthodes associées
|
ES2426005T3
(es)
|
2004-07-23 |
2013-10-18 |
Acceleron Pharma Inc. |
Polipéptidos del receptor ACTRII, procedimientos y composiciones
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
AU2006318449B2
(en)
|
2005-11-23 |
2012-07-05 |
Acceleron Pharma Inc. |
Activin-actRIIa antagonists and uses for promoting bone growth
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
EP2311505B1
(fr)
|
2006-02-09 |
2013-11-06 |
BioMimetic Therapeutics, LLC |
Compositions et méthodes pour le traitement d'os
|
CA2652549A1
(fr)
|
2006-05-17 |
2007-12-13 |
Stryker Corporation |
Procede pour traiter des defauts cartilagineux a l'aide d'uncomplexe de proteine morphogenique soluble
|
US9161967B2
(en)
|
2006-06-30 |
2015-10-20 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating the vertebral column
|
AU2007269712B2
(en)
|
2006-06-30 |
2013-02-07 |
Biomimetic Therapeutics, Llc |
PDGF-biomatrix compositions and methods for treating rotator cuff injuries
|
AU2007234612B2
(en)
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
EP2120859B1
(fr)
|
2006-12-21 |
2013-11-20 |
Stryker Corporation |
Formulations à libération entretenue comprenant des cristaux de bmp-7
|
CA2677007A1
(fr)
|
2007-02-01 |
2008-08-07 |
Acceleron Pharma Inc. |
Antagonistes de l'activine-actriia et leurs utilisations dans le traitement ou la prevention du cancer du sein
|
TWI782836B
(zh)
|
2007-02-02 |
2022-11-01 |
美商艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
TWI667038B
(zh)
|
2007-02-09 |
2019-08-01 |
美商艾瑟勒朗法瑪公司 |
包含ActRIIa-Fc融合蛋白的醫藥組合物;ActRIIa-Fc融合蛋白於治療或預防與癌症相關的骨質流失之用途;ActRIIa-Fc融合蛋白於治療或預防多發性骨髓瘤之用途
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
JP5323832B2
(ja)
|
2007-08-07 |
2013-10-23 |
アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー |
酸性水溶液中にgdf−5を含むタンパク質製剤
|
US7960343B2
(en)
|
2007-09-18 |
2011-06-14 |
Acceleron Pharma Inc. |
Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
|
JP2011514331A
(ja)
|
2008-02-13 |
2011-05-06 |
キース フルスカ, |
血管硬化症の治療における使用のためのbmp−7
|
WO2009129101A1
(fr)
|
2008-04-14 |
2009-10-22 |
Advanced Technologies And Regenerative Medicine, Llc |
Formulations liquides tamponnées de gdf-5
|
SI3750552T1
(sl)
|
2008-08-14 |
2023-10-30 |
Acceleron Pharma Inc. |
GDF pasti
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
NZ591338A
(en)
|
2008-09-09 |
2013-02-22 |
Biomimetic Therapeutics Inc |
Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
|
CA2749544A1
(fr)
|
2009-01-13 |
2010-07-22 |
Acceleron Pharma Inc. |
Procedes permettant d'augmenter l'adiponectine
|
US20100204123A1
(en)
|
2009-02-12 |
2010-08-12 |
Mary Elizabeth Pecquet Goad |
Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
|
CA2752160A1
(fr)
|
2009-02-12 |
2010-08-19 |
Stryker Corporation |
Composition et procedes d'administration systemique les moins invasifs possibles de proteines comprenant des membres de la superfamille des tgf-beta
|
WO2010110974A1
(fr)
|
2009-03-24 |
2010-09-30 |
Stryker Corporation |
Procédés et compositions pour l'ingénierie tissulaire
|
EP3845239A1
(fr)
|
2009-06-08 |
2021-07-07 |
Acceleron Pharma Inc. |
Utilisation de protéines anti-actriib pour l'augmentation d'adipocytes thermogènes
|
WO2010144696A1
(fr)
|
2009-06-11 |
2010-12-16 |
Burnham Institute For Medical Research |
Différenciation dirigée de cellules souches
|
CN107267520A
(zh)
|
2009-06-12 |
2017-10-20 |
阿塞勒隆制药公司 |
截短的actriib‑fc融合蛋白
|
US9399086B2
(en)
|
2009-07-24 |
2016-07-26 |
Warsaw Orthopedic, Inc |
Implantable medical devices
|
US20110224138A1
(en)
|
2009-09-09 |
2011-09-15 |
Julie Krop |
Methods for treating pain induced by injuries and diseases of an articular joint
|
US20110224410A1
(en)
|
2009-09-17 |
2011-09-15 |
Hile David |
Buffers for Controlling the pH of Bone Morphogenetic Proteins
|
US8710016B2
(en)
|
2009-11-17 |
2014-04-29 |
Acceleron Pharma, Inc. |
ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
AU2010341565A1
(en)
|
2009-12-22 |
2012-07-12 |
Stryker Corporation |
BMP-7 variants with reduced immunogenicity
|
CN107080834A
(zh)
|
2010-02-22 |
2017-08-22 |
生物模拟治疗有限责任公司 |
用于治疗腱病的血小板衍生生长因子组合物和方法
|
WO2011139594A2
(fr)
|
2010-04-27 |
2011-11-10 |
Medtronic, Inc. |
Bourse artificielle pour administration de médicament intra-articulaire
|
CN103298832A
(zh)
|
2010-11-08 |
2013-09-11 |
阿塞勒隆制药公司 |
Actriia结合剂及其用途
|
US9809636B2
(en)
*
|
2012-04-06 |
2017-11-07 |
Acceleron Pharma Inc. |
Methods for increasing red blood cell levels comprising administering BMP9
|
WO2014012101A1
(fr)
|
2012-07-13 |
2014-01-16 |
Trustees Of Tufts College |
Compactage de poudre de soie pour fabrication de constructions à résistance mécanique et rigidité élevées
|
CA2890217C
(fr)
|
2012-11-02 |
2021-07-20 |
Yifu FANG |
Antagonistes d'activine-actrii et utilisations pour le traitement de troubles osseux et autres
|
AU2014253753B2
(en)
|
2013-04-19 |
2017-03-30 |
Theracell, Inc. |
Demineralized bone fibers having controlled geometry and shapes and methods thereof
|
WO2015192111A1
(fr)
|
2014-06-13 |
2015-12-17 |
Acceleron Pharma, Inc. |
Méthodes et compositions de traitement d'ulcères
|
GB201412290D0
(en)
|
2014-07-10 |
2014-08-27 |
Cambridge Entpr Ltd |
Novel use
|
MA41052A
(fr)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
|
BR112017011722A2
(pt)
|
2014-12-03 |
2018-02-27 |
Acceleron Pharma Inc |
antagonistas de activina-actrii e usos para o tratamento de anemia
|
US10610366B2
(en)
|
2015-01-29 |
2020-04-07 |
Theracell, Inc. |
Demineralized bone fiber composition for use in minimally invasive surgery
|
EP3310337B1
(fr)
|
2015-06-17 |
2021-03-03 |
Warsaw Orthopedic, Inc. |
Implants comprenant un oxystérol et procédés d'utilisation
|
EP3821880A1
(fr)
|
2015-10-26 |
2021-05-19 |
President and Fellows of Harvard College |
Polysaccharides oxydés et leurs méthodes d'utilisation
|
US10688222B2
(en)
|
2016-11-21 |
2020-06-23 |
Warsaw Orthopedic, Inc. |
Lyophilized moldable implants containing an oxysterol
|
US10639157B2
(en)
|
2017-03-14 |
2020-05-05 |
Theracell, Inc. |
Demineralized bone fiber composition for use in minimally invasive surgery
|
US11464888B2
(en)
|
2017-06-12 |
2022-10-11 |
Warsaw Orthopedic, Inc. |
Moldable formulations containing an oxysterol in an acellular tissue matrix
|
US11103618B2
(en)
|
2018-02-22 |
2021-08-31 |
Warsaw Orthopedic, Inc. |
Demineralized bone matrix having improved handling characteristics
|
US11498880B2
(en)
|
2019-07-26 |
2022-11-15 |
Warsaw Orthopedic, Inc. |
Calcium phosphate granules and methods of making them
|
CN113603792B
(zh)
*
|
2021-08-26 |
2023-06-30 |
深圳市人民医院 |
一种重组骨形态发生蛋白-2及其制备方法和应用
|